TickerFacts.

Biomerica Inc (BMRA): Cash & Equivalents

Annual figures by period end, from SEC filings.

$1.31M
As of 2026-05-31
-48.8%
3-year compound annual growth
-20.8%
5-year compound annual growth
-3.6%
10-year compound annual growth
$9.72M2011-05-31: $989.3K2012-05-31: $1.08M2013-05-31: $2.47M2014-05-31: $1.51M2015-05-31: $1.09M2016-05-31: $1.89M2017-05-31: $1.23M2018-05-31: $1.20M2019-05-31: $686.8K2020-05-31: $8.64M2021-05-31: $4.20M2022-05-31: $5.92M2023-05-31: $9.72M2024-05-31: $4.17M2025-05-31: $2.40M2026-05-31: $1.31M$1.31M
2011-05-31 Cash & Equivalents (USD) 2026-05-31
Period endedCash & EquivalentsChange YoYSource filing
2026-05-31$1.31M-45.5%2026-08-31, Balance as of period end
2025-05-31$2.40M-42.5%2026-08-31, Balance as of period end
2024-05-31$4.17M-57.1%2025-08-29, Balance as of period end
2023-05-31$9.72M+64.3%2024-08-28, Balance as of period end
2022-05-31$5.92M+40.9%2023-08-25, Balance as of period end
2021-05-31$4.20M-51.4%2022-08-29, Balance as of period end
2020-05-31$8.64Mn/m2021-10-14, Balance as of period end
2019-05-31$686.8K-43.0%2020-08-31, Balance as of period end
2018-05-31$1.20M-1.7%2019-08-29, Balance as of period end
2017-05-31$1.23M-35.1%2018-08-29, Balance as of period end
2016-05-31$1.89M+73.6%2017-08-29, Balance as of period end
2015-05-31$1.09M-27.9%2016-08-29, Balance as of period end
2014-05-31$1.51M-38.9%2015-08-31, Balance as of period end
2013-05-31$2.47M+129.2%2014-08-29, Balance as of period end
2012-05-31$1.08M+8.9%2013-08-29, Balance as of period end
2011-05-31$989.3Kn/a2012-08-29, Balance as of period end

Cash & Equivalents at similar companies

Companies with the same SEC industry code (In Vitro & In Vivo Diagnostic Substances), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCash & EquivalentsChange YoY
Biomerica Inc (BMRA)2026-05-31$1.31M-45.5%
Insight Molecular Diagnostics Inc. (IMDX)2025-12-31$11.58M+34.1%
Anbio Biotechnology (NNNN)2025-12-31$7.77M-34.0%
Aspira Women's Health Inc. (AWHL)2025-12-31$1.75M-0.8%
Volitionrx Ltd (VNRX)2025-12-31$1.12M-65.8%
Celldex Therapeutics, Inc. (CLDX)2025-12-31$28.87M+1.8%
Immucell Corp (ICCC)2025-12-31$3.81M+1.3%
Alpha Teknova, Inc. (TKNO)2025-12-31$5.91M+59.4%
Intellia Therapeutics, Inc. (NTLA)2025-12-31$155.46M-17.8%

Compare BMRA, IMDX, NNNN, AWHL side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗